Virtual Exposure With Response Prevention for Obsessive-Compulsive Disorder: Randomized Controlled Trial - Report - MDSpire

Virtual Exposure With Response Prevention for Obsessive-Compulsive Disorder: Randomized Controlled Trial

  • By

  • Lara Rolvien

  • Lena Jelinek

  • Luzie Lohse

  • Steffen Moritz

  • Lisa Borgmann

  • Jürgen Gallinat

  • Simone Kühn

  • Franziska Miegel

  • May 27, 2026

  • 0 min

Share

Clinical Report: Efficacy of Virtual Exposure Therapy in OCD Treatment

Overview

This study evaluates the efficacy of virtual exposure therapy with response prevention (VRET) for treating obsessive-compulsive disorder (OCD). The findings suggest that VRET may address barriers to traditional exposure therapy, potentially improving treatment access and patient engagement.

Background

Obsessive-compulsive disorder (OCD) is a prevalent and debilitating condition that significantly impacts patients' quality of life. Traditional cognitive behavioral therapy (CBT) with exposure and response prevention (ERP) is the recommended first-line treatment, yet its implementation faces numerous barriers. Virtual reality exposure therapy (VRET) presents a novel approach that may help overcome these challenges by providing a controlled and safe environment for exposure.

Data Highlights

No numerical data or trial results were provided in the source material.

Key Findings

  • OCD has a lifetime prevalence of 1.3% to 2.5% and is a leading cause of disability.
  • ERP is the first-line treatment for OCD, but its use is often below 50% due to various barriers.
  • VRET offers a safe environment that may enhance patient acceptance and reduce refusal rates for exposure therapy.
  • VRET has shown efficacy for various anxiety disorders, though its superiority to traditional ERP is not universally established.
  • Therapists report logistical challenges and stress associated with conducting traditional ERP.

Clinical Implications

VRET may provide a viable alternative to traditional ERP, potentially improving treatment adherence among patients with OCD. Clinicians should consider integrating VRET into their therapeutic practices to address common barriers faced in conventional exposure therapy.

Conclusion

The study highlights the potential of VRET as an innovative approach to enhance the treatment of OCD, addressing both patient and therapist-related barriers to traditional exposure therapy.

Related Resources & Content

  1. BMC Psychiatry (Springer), 2025 -- Efficacy and safety profile of vortioxetine as an add-on molecule in obsessive-compulsive disorder: a randomized double-blinded placebo-controlled superiority trial – a study protocol
  2. Frontiers in Digital Health, 2026 -- A Systematic Review of Virtual Reality Applications in the Management of Psychological Disorders
  3. npj Digital Medicine, 2025 -- A Randomized Clinical Study Comparing App-Based Cognitive Behavioral Therapy and HealthWatch for Treating Obsessive-Compulsive Disorder
  4. BMC Psychiatry (Springer), 2025 -- Motivation in the Bergen 4-day treatment for obsessive–compulsive disorder
  5. NICE, 2024 -- Overview | Obsessive-compulsive disorder and body dysmorphic disorder: treatment
  6. JAMA Network Open, 2025 -- Exposure Therapy in Mixed Reality for Obsessive-Compulsive Disorder: A Randomized Clinical Trial
  7. PubMed, 2024 -- Internet-Based Cognitive Behavioural Treatments for Obsessive-Compulsive Disorder: A Systematic Review and Meta-Analysis
  8. Overview | Obsessive-compulsive disorder and body dysmorphic disorder: treatment | Guidance | NICE
  9. Exposure Therapy in Mixed Reality for Obsessive-Compulsive Disorder: A Randomized Clinical Trial | Psychotherapy | JAMA Network Open | JAMA Network
  10. Internet-Based Cognitive Behavioural Treatments for Obsessive-Compulsive Disorder: A Systematic Review and Meta-Analysis - PubMed

Original Source(s)

Related Content